It is a pharma private limited company based in Hyderabad, Telangana, India, established in 2004.
2004 | Hyderabad, Telangana, India | ActiveExela Pharm Sci Private Limited, a active private limited company, was established on 26 May 2004 in Hyderabad, Telangana, India. Engaging in pharmaceutical retailers & distributors within the manufacturing sector, it holds CIN: U24231TG2004PTC125972. Registered under ROC Roc Hyderabad. it is unlisted. It has an authorized capital of ₹3.00 Cr and a paid-up capital of ₹1.93 Cr.
It upholds a compliant status. Its leadership includes Murali Krishna Reddy Adala (Director), Saba Nayagam Ganapathi (Director), Phanesh Babu Koneru (Director). Past directors included Sree Rama Murthy Mallipeddi. Its latest AGM occurred on 30 September 2024, with the balance sheet filed on 31 March 2024. It is based at 4Th Floor, Park Citi Plaza, Road No.1 Banjara Hills, Hyderabad, Telangana, 500082.
U24231TG2004PTC125972
125972
26 May 2004
₹3.00 Cr
₹1.93 Cr
Roc Hyderabad
Unlisted
Active
Explore comprehensive insights into Exela Pharm Sci Private Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.
Access Report
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Murali Krishna Reddy Adala | Director | 26 May 2004 | Current |
| Saba Nayagam Ganapathi | Director | 11 Jul 2016 | Current |
| Phanesh Babu Koneru | Director | 29 Sep 2005 | Current |
| Name | Designation | Cessation | Status |
|---|---|---|---|
| Pramod Abcsdd | Director | 03 Sep 2007 | Past |
Discover detailed profiles of directors and KMP - Unlock leadership insights today!
Exela Pharm Sci Private Limited, for the financial year ended 2021, experienced Minor drop in revenue, with a 4.67% decrease. The company also saw a substantial fall in profitability, with a 38.83% decrease in profit. The company's net worth moved up by a moderate rise of 6.58%.
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations | |||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
In 2021, Exela Pharm Sci had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Reveal ownership structures and financial performance - Get instant access now!
There are no open charges registered against the company as per our records.
Unlock and access historical data on people associated with Exela Pharm Sci, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Gain comprehensive insights into the Deals and Valuation data of Exela Pharm Sci, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Exela Pharm Sci's trajectory.
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
Progress on Exela Pharm Sci Private Limited last Annual general meeting of members was held on 30 Sep 2024 as per latest MCA records. was documented.
The activity Exela Pharm Sci Private Limited has filed its annual Financial statements for the year ended 31 Mar 2024 with Roc Hyderabad. was completed.
The activity Saba Nayagam Ganapathi was appointed as a Director was appointed as a Director on 11 Jul 2016 & has been associated with this company since 9 years 4 months . was completed.
The activity Phanesh Babu Koneru was appointed as a Director was appointed as a Director on 29 Sep 2005 & has been associated with this company since 20 years 2 months . was completed.
Progress on Murali Krishna Reddy Adala was appointed as a Director was appointed as a Director on 26 May 2004 & has been associated with this company since 21 years 6 months . was documented.
Exela Pharm Sci Private Limited was registered on 26 May 2004 with Roc Hyderabad & aged 21 years 6 months as per MCA records. was recorded as a recent event.
The CIN of Exela Pharm Sci Private Limited is U24231TG2004PTC125972.
Exela Pharm Sci Private Limited is headquartered at 4Th Floor, Park Citi Plaza, Road No.1 Banjara Hills, Hyderabad, Telangana, 500082.
Exela Pharm Sci Private Limited was incorporated on 26 May 2004.
The current directors of Exela Pharm Sci Private Limited are
The primary industry of Exela Pharm Sci Private Limited is Manufacturing.
Exela Pharm Sci Private Limited is unlisted.
The authorized capital of Exela Pharm Sci Private Limited is ₹3.00 Cr, and the paid-up capital is ₹1.93 Cr.
The compliance status of Exela Pharm Sci Private Limited is Compliant.
Search company & director profiles for free and gain access to critical business data.
Company Details
+91-XXXXXXXXXX